Continued Treatment with Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Interim Analysis of SENSCIS-ON - Gläser, S; Allanore, Y; Vonk, M C; Azuma, A; Mayes, M D; Gahlemann, M; James, A; Kohlbrenner, V; Stowasser, S; Highland, K B (Pneumologie, 2021)